Nicotinamide Riboside (NR) Market Report 2026

Nicotinamide Riboside (NR) Market Overview

• Nicotinamide Riboside (NR) market size has reached to $1.81 billion in 2025 • Expected to grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 12.3% • Growth Driver: Rising Health Consciousness Among Consumers Fueling The Growth Of The Market Due To Demand For Cellular Energy And Healthy Aging Supplements • Market Trend: Advanced Formulations Drive Innovation In Healthy Aging Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nicotinamide Riboside (NR) Market?

Nicotinamide riboside (NR) is a naturally occurring form of vitamin B3 and a precursor to nicotinamide adenine dinucleotide (NAD⁺), a critical coenzyme in cellular energy metabolism. Its primary purpose is to boost NAD⁺ levels in cells, supporting mitochondrial function, energy production, and healthy aging. It is often used as a dietary supplement to enhance metabolic health and promote overall cellular vitality. The main product types of nicotinamide riboside (NR) products include capsules, tablets, powders, and other product types. Capsules refer to orally administered nicotinamide riboside formulations designed to support cellular energy metabolism, healthy aging, and overall wellness. The distribution channels such as online retail, health and wellness stores, pharmacies and drugstores, supermarkets and hypermarkets, and specialty stores. The applications such as across dietary supplements, pharmaceuticals, cosmetics and personal care products, food and beverage, and animal nutrition and the key across dietary supplements, pharmaceuticals, cosmetics and personal care products, food and beverage, and animal nutrition.

What Is The Nicotinamide Riboside (NR) Market Growth Forecast?

The nicotinamide riboside (NR) market size is expected to see rapid growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to growing demand for longevity and cellular rejuvenation products, increasing interest in personalized wellness and precision nutrition, rising incorporation of NR into multi-ingredient formulations, expansion of distribution across pharmacies and specialty health stores, growing investments from nutraceutical and pharmaceutical manufacturers. Major trends in the forecast period include technology advancements in nr formulation stability and bioavailability, innovations in delivery systems such as sustained release capsules, developments in functional food and beverage fortification with nr, research and development in nad⁺ pathway therapeutics, advancements in DNA-based and biomarker-driven supplement customization.

Global Nicotinamide Riboside (NR) Market Segmentation

1) By Product Type: Capsules, Tablets, Powders, Other Product Types 2) By Distribution Channel: Online Retail, Health and Wellness Stores, Pharmacies and Drugstores, Supermarkets and Hypermarkets, Specialty Stores 3) By Application: Dietary Supplements, Pharmaceuticals, Cosmetics and Personal Care Products, Food and Beverage, Animal Nutrition 4) By End-User: Fitness Enthusiasts, Aging Population, General Consumers, Healthcare Institutions, Research and Academic Institutions Subsegments: 1) By Capsules: Vegetarian Capsules, Gelatin Capsules, Sustained Release Capsules, Fast Dissolution Capsules, Enteric Coated Capsules 2) By Tablets: Coated Tablets, Chewable Tablets, Effervescent Tablets, Sublingual Tablets, Extended Release Tablets 3) By Powders: Flavored Powders, Unflavored Powders, Water Soluble Powders, Effervescent Powders, Single Serve Sachet Powders 4) By Other Product Types: Softgels, Liquid Oral Drops, Gummies, Functional Beverages, Fortified Food Products

What Is The Driver Of The Nicotinamide Riboside (NR) Market?

The rising health consciousness among consumers is expected to propel the growth of the nicotinamide riboside (NR) market going forward. Health consciousness among consumers refers to the awareness and proactive attitude of individuals toward maintaining good health through their lifestyle and dietary choices. The rise in health-conscious eating is due to increasing awareness of diet-related diseases, motivating more people to choose nutritious foods and reduce sugar intake. Health consciousness enhances nicotinamide riboside (NR) adoption by driving consumer demand for supplements that support cellular energy, healthy aging, and metabolic function. It improves market growth by encouraging proactive wellness behaviors and interest in scientifically backed nutritional ingredients. For instance, in June 2024, according to the International Food Information Council, a US-based nonprofit organization, most Americans are increasingly focused on consuming more protein, rising from 59% in 2022 to 67% in 2023 and 71% in 2024. Therefore, the rising health consciousness among consumers is driving the growth of the nicotinamide riboside (NR) industry.

Key Players In The Global Nicotinamide Riboside (NR) Market

Major companies operating in the nicotinamide riboside (nr) market are Zhejiang NHU Company Ltd., Designs for Health Inc., Niagen Bioscience Inc., Cayman Chemical Company, Jinan Qinmu Fine Chemical Co. Ltd, Simson Pharma Limited, Runtai Chemical, Double Wood Supplements LLC, DoNotAge.org Ltd., Bontac Bio-engineering (Shenzhen) Co. Ltd., Hangzhou Longshine Bio-Tech Co. LTD, Renue By Science LLC, Kavya Pharma, China Qingdao Hong Jin Chemical Co. Ltd., Chemvon Biotechnology (Shanghai) Co. Ltd., Dravyom Chemical Company, Fengchen Group Co. Ltd, Hangzhou Weitai Biological Pharmaceutical Co. Ltd., Suzhou Myland Nutraceuticals Inc., Chromadex Inc.

Global Nicotinamide Riboside (NR) Market Trends and Insights

Major companies operating in the nicotinamide riboside (NR) market are focusing on developing advanced formulations, such as nicotinamide adenine dinucleotide (NAD+) skincare supplements, to support anti-aging and improve skin health. Nicotinamide adenine dinucleotide (NAD+) skincare supplements refer to dietary or topical products formulated to increase nicotinamide adenine dinucleotide (NAD+) levels in skin cells, supporting cellular energy, repair, and anti-aging processes to improve skin health and appearance. For instance, in April 2024, ChromaDex Corporation, a US-based NAD+ bioscience company, launched Tru Niagen at The Vitamin Shoppe. It is a healthy-aging nicotinamide adenine dinucleotide (NAD+) supplement designed to elevate NAD⁺ levels safely and effectively in adults, supporting cellular health, energy production, and overall well-being. The nationwide rollout makes the product readily available to consumers seeking science-based support for age-related declines in metabolic function.

What Are Latest Mergers And Acquisitions In The Nicotinamide Riboside (NR) Market?

In October 2023, L Catterton Management Company LLC, a US-based consumer-focused investment firm, acquired Thorne HealthTech Inc. for an undisclosed amount. With this acquisition, L Catterton expanded its presence in personalized wellness and longevity-oriented nutrition markets, leveraging Thorne’s established product portfolio, research and development capabilities, and direct-to-consumer reach. Thorne HealthTech Inc. is a US-based nutritional supplement company specializing in nicotinamide riboside (NR) products for cellular and healthy aging support.

Regional Insights

North America was the largest region in the nicotinamide riboside market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nicotinamide Riboside (NR) Market?

The nicotinamide riboside (NR) market consists of sales of capsules, tablets, and powder supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nicotinamide Riboside (NR) Market Report 2026?

The nicotinamide riboside (nr) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nicotinamide riboside (nr) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.